| Disease | hypothyroidism |
| Comorbidity | C0278678|metastatic renal cell carcinoma |
| Sentences | 1 |
| PubMedID- 25442773 | hypothyroidism in patients with metastatic renal cell carcinoma (mrcc) during treatment with the tyrosine kinase inhibitors (tkis) sunitinib and sorafenib is a well-established side effect. |
Page: 1